Zoetis Inc. (ZTS) News
Filter ZTS News Items
ZTS News Results
|Loading, please wait...|
ZTS News Highlights
- For ZTS, its 30 day story count is now at 31.
- Over the past 26 days, the trend for ZTS's stories per day has been choppy and unclear. It has oscillated between 1 and 8.
- The most mentioned tickers in articles about ZTS are PET, ASRT and AMP.
Latest ZTS News From Around the Web
Below are the latest news stories about ZOETIS INC that investors may wish to consider to help them evaluate ZTS as an investment opportunity.
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), The Coca-Cola Company (KO) and The Progressive (PGR).
PARSIPPANY, N.J., November 29, 2022--Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022. Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices, will represent the company and respond to questions from analysts. He is scheduled to present at 3:30 p.m. ET.
Today we will run through one way of estimating the intrinsic value of Zoetis Inc. ( NYSE:ZTS ) by taking the expected...
ASRT vs. ZTS: Which Stock Is the Better Value Option?
Many Zoetis Inc. ( NYSE:ZTS ) insiders ditched their stock over the past year, which may be of interest to the...
For Zoetis Inc. (NYSE:ZTS) insiders, selling US$863k worth of stock earlier this year was a smart move.
Despite the fact that Zoetis Inc. (NYSE:ZTS) stock rose 11% last week, insiders who sold US$863k worth of stock in the...
Zoetis and Medtronic are among the healthcare stocks with the most room to rise, according to Wall Street analysts' average price targets.
Morgan Stanley analyst Erin Wright maintained a Buy rating on Zoetis (ZTS - Research Report) today and set a price target of $248.00. The company's shares opened today at $149.70.According to TipRanks, Wright is a 5-star analyst with an average return of 16.2% and a 65.66% success rate. Wright covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA, Cardinal Health, and Phibro Animal Health.The word on The Street in general, suggests a Strong Buy analyst consensus rating for Zoetis with a $208.83 average price target, a 39.50% upside from current levels.
In this article we present the list of 10 Best 52-Week Low Stocks To Buy Now. Click to skip ahead and see the 5 Best 52-Week Low Stocks To Buy Now. Microsoft Corporation (NASDAQ:MSFT), Amazon.com, Inc. (NASDAQ:AMZN), and Meta Platforms, Inc. (NASDAQ:META) are three of the biggest companies in the world that have all hit 52-week […]
Zoetis (NYSE:ZTS) jumps 11% this week, though earnings growth is still tracking behind five-year shareholder returns
It hasn't been the best quarter for Zoetis Inc. ( NYSE:ZTS ) shareholders, since the share price has fallen 15% in that...